Louisiana State Employees Retirement System I Teos Therapeutics, Inc. Transaction History

Louisiana State Employees Retirement System

  • $5.33 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 17, 2023
BUY
$10.95 - $14.6 $5,475 - $7,300
500 Added 3.85%
13,500 $147,000
Q2 2023

Jul 18, 2023
BUY
$12.93 - $18.05 $20,688 - $28,880
1,600 Added 14.04%
13,000 $172,000
Q1 2023

Apr 19, 2023
SELL
$13.02 - $22.62 $3,906 - $6,786
-300 Reduced 2.56%
11,400 $155,000
Q3 2022

Oct 19, 2022
BUY
$18.6 - $27.25 $35,340 - $51,775
1,900 Added 19.39%
11,700 $223,000
Q1 2022

Apr 22, 2022
BUY
$31.92 - $47.45 $312,816 - $465,010
9,800 New
9,800 $304,000

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email